Css LLC Mereo Biopharma Group PLC Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.6 - $4.43 $10,400 - $17,720	-4,000 Reduced 27.15%	10,735 $36,000
Q4 2020 Feb 16, 2021	SELL	$1.95 - $3.6 $78,074 - $144,136	-40,038 Reduced 73.1%	14,735 $53,000
Q2 2020 Aug 14, 2020	SELL	$1.0 - $3.4 $20,000 - $68,000	-20,000 Reduced 26.75%	54,773 $168,000
Q1 2020 May 15, 2020	BUY	$0.8 - $3.21 $18,059 - $72,462	22,574 Added 43.25%	74,773 $78,000
Q4 2019 Feb 14, 2020	SELL	$1.1 - $3.7 $28,608 - $96,229	-26,008 Reduced 33.26%	52,199 $171,000
Q3 2019 Nov 14, 2019	BUY	$2.22 - $4.14 $2,342 - $4,367	1,055 Added 1.37%	78,207 $233,000
Q2 2019 Aug 14, 2019	BUY	$2.52 - $6.5 $194,423 - $501,488	77,152 New	77,152 $195,000

114M

83.4K

424K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $366M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.